This was the stock's fourth consecutive day of losses.

Analysts at HC Wainwright upped their FY2024 earnings estimates for Inovio Pharmaceuticals in a research report issued on ...

Inovio Pharmaceuticals Inc (INO) stock saw a decline, ending the day at $2.09 which represents a decrease of $-0.19 or -8.33% from the prior close of $2.28. The stock opened at $2.36 and touched a low ...

Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report)‘s stock had its “market outperform” rating restated by JMP Securities ...

Inovio Pharmaceuticals shares are trading higher by 20.7% Tuesday afternoon. Vaccine stocks are rising amid growing concerns ...

JMP Securities analyst Roy Buchanan reiterated a Buy rating on Inovio Pharmaceuticals (INO – Research Report) today and set a price target of ...

Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...

Stephens has recently initiated Inovio Pharmaceuticals Inc (INO) stock to Overweight rating, as announced on May 14, 2024, according to Finviz. Earlier, on January 25, 2024, Oppenheimer had raised the ...

Like most office property landlords, INO has had a few rough years. Data by YCharts We started covering this stock in December 2022. Its downward spiral was well underway at that time, with one of ...

Inovio Pharmaceuticals Inc. closed $12.66 below its 52-week high ($14.75), which the company reached on April 1st.